AstraZeneca
AZN
#43
Rank
A$446.74 B
Marketcap
A$288.17
Share price
-1.09%
Change (1 day)
27.73%
Change (1 year)

AstraZeneca (AZN) - Cash on Hand

Cash on Hand as of December 2025 : A$8.10 Billion

According to AstraZeneca's latest financial reports the company has A$8.10 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

AstraZeneca - Cash on Hand chart (from 1996 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2025-12-31A$8.57 B-3.51%
2024-12-31A$8.88 B3.27%
2023-12-31A$8.60 B-6.24%
2022-12-31A$9.17 B3.95%
2021-12-31A$8.82 B-15.09%
2020-12-31A$10.39 B17.05%
2019-12-31A$8.87 B11.82%
2018-12-31A$7.94 B36.13%
2017-12-31A$5.83 B-27.64%
2016-12-31A$8.06 B-12.91%
2015-12-31A$9.25 B7.59%
2014-12-31A$8.60 B-22.44%
2013-12-31A$11.09 B40.18%
2012-12-31A$7.91 B-28.05%
2011-12-31A$10.99 B-5.53%
2010-12-31A$11.64 B-8.28%
2009-12-31A$12.69 B103.94%
2008-12-31A$6.22 B-8.67%
2007-12-31A$6.81 B-30.09%
2006-12-31A$9.74 B43.25%
2005-12-31A$6.80 B0.02%
2004-12-31A$6.80 B28%
2003-12-31A$5.31 B-36.12%
2002-12-31A$8.32 B11.08%
2001-12-31A$7.49 B-5.93%
2000-12-31A$7.96 B59.15%
1999-12-31A$5.00 B-10.21%
1998-12-31A$5.57 B201.25%
1997-12-31A$1.84 B-11.99%
1996-12-31A$2.10 B

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Johnson & Johnson
JNJ
A$28.36 B 250.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$16.27 B 100.89%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
A$21.14 B 161.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
A$10.91 B 34.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$10.25 B 26.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
A$14.74 B 82.06%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
A$5.38 B-33.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$25.70 B 217.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$15.06 B 85.91%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
A$6.27 B-22.59%๐Ÿ‡ฌ๐Ÿ‡ง UK